TA-1 (Thymosin Alpha-1)

Description

Thymosin Alpha-1 is a naturally occurring 28-amino-acid peptide derived from the N-terminal region of prothymosin alpha. The thymosin alpha 1 structure is characterized by an acetylated N-terminus and a highly acidic amino acid sequence. Structural studies have also examined how the peptide adopts different conformations depending on its surrounding experimental environment.

The TA 1 peptide is widely studied in laboratory models involving immune signaling and thymus-associated cellular processes. TA 1 immune system research has examined pathways connected with T-cell activity, immune-cell differentiation, cytokine signaling, and other mechanisms associated with immune regulation. These areas remain subjects of experimental and translational investigation.

Features

• Composition: 28-amino-acid peptide
• Origin: Corresponds to the N-terminal 28 residues of prothymosin alpha
• N-Terminal Modification: Acetylated
• Structural Characteristic: Highly acidic peptide
• Research Classification: Thymic peptide
• Research Focus: Immune-cell signaling, T-cell-associated pathways, cellular differentiation, and immune regulatory mechanisms
• Format: Supplied as lyophilized research material
• Recommended Storage: −20 °C unless otherwise specified by batch documentation

Disclaimer: Supplied strictly for laboratory research. FDA notes that safety information for compounded thymosin-alpha 1 remains inadequate for establishing human safety. This product is not intended for human or veterinary use, administration, consumption, diagnosis, treatment, or therapeutic purposes.